184 related articles for article (PubMed ID: 8229662)
1. [Research and development of new oral cephems, cefixime and cefdinir].
Sakane K; Kawabata K; Inamoto Y; Yamanaka H; Takaya T
Yakugaku Zasshi; 1993 Sep; 113(9):605-26. PubMed ID: 8229662
[TBL] [Abstract][Full Text] [Related]
2. [Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
Toyonaga Y; Hatakeyama K; Yamori K; Sakaguchi N; Nakano K; Yamazaki M; Sugita M; Hori M
Jpn J Antibiot; 1992 Jan; 45(1):48-73. PubMed ID: 1495196
[TBL] [Abstract][Full Text] [Related]
3. [A new oral cephem, cefdinir: its structure-activity relationships and biological profile].
Sakane K; Inamoto Y; Takaya T
Jpn J Antibiot; 1992 Aug; 45(8):909-25. PubMed ID: 1433897
[TBL] [Abstract][Full Text] [Related]
4. [Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory].
Nakamura T; Takahashi H
Jpn J Antibiot; 2004 Dec; 57(6):465-74. PubMed ID: 15747584
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity of FK482, a new orally active cephalosporin.
Mine Y; Kamimura T; Watanabe Y; Tawara S; Matsumoto Y; Shibayama F; Kikuchi H; Takaya T; Kuwahara S
J Antibiot (Tokyo); 1988 Dec; 41(12):1873-87. PubMed ID: 3264828
[TBL] [Abstract][Full Text] [Related]
6. [Studies on FK482. II. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-substituted acetamido]-3-vinyl-3-cephem-4-carboxylic acid derivatives].
Inamoto Y; Chiba T; Sakane K; Kamimura T; Takaya T
Yakugaku Zasshi; 1990 Apr; 110(4):246-57. PubMed ID: 2376819
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. I.
Kim WJ; Ko KY; Kim H; Oh J
J Antibiot (Tokyo); 1991 Oct; 44(10):1073-82. PubMed ID: 1955389
[TBL] [Abstract][Full Text] [Related]
8. [Studies on FK482 (Cefdinir). IV. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]- 3-substituted cephalosporin derivatives].
Inamoto Y; Sakane K; Kamimura T; Takaya T
Yakugaku Zasshi; 1990 Dec; 110(12):908-15. PubMed ID: 2074536
[TBL] [Abstract][Full Text] [Related]
9. [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
Bauernfeind A; Jungwirth R; Schweighart S; Theopold M
Infection; 1990; 18 Suppl 3():S155-67. PubMed ID: 2079378
[TBL] [Abstract][Full Text] [Related]
10. [Structure-activity relationship of oral cephalosporins].
Bingen E; Lambert-Zechovsky N
Presse Med; 1989 Nov; 18(39):1923-7. PubMed ID: 2531868
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antibacterial activity and pharmacokinetics of SC-002 and its derivative, SC-004: new oral cephalosporins.
Nagate T; Akashi T; Numata K; Sugita K; Kaneda Y; Matsuyama M; Saito H; Nozawa M; Onodera A; Hanada K; Kobori T; Fujita M; Yamamoto R; Hiyama T; Kondo K
Chemotherapy; 2001; 47(3):157-69. PubMed ID: 11306784
[TBL] [Abstract][Full Text] [Related]
12. Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Gerlach EH; Jones RN; Allen SD; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):537-43. PubMed ID: 1424507
[TBL] [Abstract][Full Text] [Related]
13. [Fundamental and clinical studies of cefixime granules in pediatrics].
Sunakawa K; Saito N; Ishizuka Y; Iwata S; Kumagai N; Yokota T; Asaishi T; Kusano S; Sato Y; Kusumoto Y
Jpn J Antibiot; 1986 Apr; 39(4):1035-54. PubMed ID: 3761536
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
Matsui H; Hiraoka M; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Apr; 34(4):555-61. PubMed ID: 2344162
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients.
Sultan T; Baltch AL; Smith RP; Ritz W
Chemotherapy; 1994; 40(2):80-91. PubMed ID: 8131638
[TBL] [Abstract][Full Text] [Related]
16. Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.
Debbia EA; Marchese A; Pesce A; Saverino D; Schito GC
J Chemother; 1992 Jun; 4(3):131-44. PubMed ID: 1517806
[TBL] [Abstract][Full Text] [Related]
17. [Cefixime, the first oral third-generation cephalosporin].
Roche G
Presse Med; 1989 Oct; 18(32):1541-4. PubMed ID: 2530527
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of FK041, a new orally active cephalosporin.
Watanabe Y; Hatano K; Matsumoto Y; Tawara S; Yamamoto H; Kawabata K; Takasugi H; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845
[TBL] [Abstract][Full Text] [Related]
19. Studies on cephalosporin antibiotics. IV. Synthesis, antibacterial activity and oral absorption of new 3-(2-substituted-vinylthio)-7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2- (carboxymethoxyimino)acetamido]cephalosporins.
Yokoo C; Goi M; Onodera A; Fukushima H; Nagate T
J Antibiot (Tokyo); 1991 Dec; 44(12):1422-31. PubMed ID: 1778793
[TBL] [Abstract][Full Text] [Related]
20. Studies on cephalosporin antibiotics. VI. Synthesis, antibacterial activity and oral efficacy in mice of new 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)-acetamido]-3- (substituted alkylthio)cephalosporins.
Yokoo C; Onodera A; Fukushima H; Numata K; Nagate T
J Antibiot (Tokyo); 1992 Sep; 45(9):1533-9. PubMed ID: 1429240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
